Associations of sleep disturbance and duration with metabolic risk factors in obese persons with type 2 diabetes: data from the Sleep AHEAD Study

Purpose Some studies have found an association between sleep disturbances and metabolic risk, but none has examined this association in individuals with type 2 diabetes. The objective of this study was to determine the relationship between sleep disturbances and metabolic risk factors in obese patients with type 2 diabetes. Patients and methods This study was a cross-sectional examination of the relationship between sleep parameters (apnea/hypopnea index [AHI], time spent in various sleep stages) and metabolic risk markers (fasting glucose, hemoglobin A1c, lipids) using baseline data of the Sleep AHEAD cohort. Subjects (n = 305) were participants in Sleep AHEAD (Action for Health in Diabetes), a four-center ancillary study of the Look AHEAD study, a 16-center clinical trial of overweight and obese participants with type 2 diabetes, designed to assess the long-term effects of an intensive lifestyle intervention on cardiovascular events. All participants underwent one night of in-home polysomnography and provided a fasting blood sample. Regression analyses estimated the relationship between sleep variables and metabolic risk factors. Models were adjusted for study center, age, sex, race/ethnicity, waist circumference, smoking, alcohol intake, diabetes duration, and relevant medications. Results Of 60 associations tested, only one was significant: fasting glucose was associated with sleep efficiency (estimate −0.53 ± [standard error] 0.26, P = 0.041). No associations were found between any of the sleep variables and lipid profile or hemoglobin A1c. Conclusions The present data show only weak associations between select sleep variables and metabolic risk factors and do not provide strong support for a role of sleep on metabolic abnormalities in obese patients with type 2 diabetes.

[1]  S. Tufik,et al.  Consequences of obstructive sleep apnea on metabolic profile: A Population‐Based Survey , 2012, Obesity.

[2]  Daniel J Buysse,et al.  Sleep is associated with the metabolic syndrome in a multi-ethnic cohort of midlife women: the SWAN Sleep Study. , 2012, Sleep.

[3]  T. Tung,et al.  Impact of subjective sleep quality on glycemic control in type 2 diabetes mellitus. , 2012, Family practice.

[4]  E. Maltezos,et al.  Continuous Positive Airway Pressure Treatment: Effect on Serum Lipids in Patients with Obstructive Sleep Apnoea , 2011, The open cardiovascular medicine journal.

[5]  Swastik Agrawal,et al.  CPAP for the metabolic syndrome in patients with obstructive sleep apnea. , 2011, The New England journal of medicine.

[6]  Oliver Senn,et al.  Effects of continuous positive airway pressure therapy withdrawal in patients with obstructive sleep apnea: a randomized controlled trial. , 2011, American journal of respiratory and critical care medicine.

[7]  N. Salord,et al.  Obstructive sleep apnoea and metabolic impairment in severe obesity , 2011, European Respiratory Journal.

[8]  E. van Cauter,et al.  Cross-Sectional Associations Between Measures of Sleep and Markers of Glucose Metabolism Among Subjects With and Without Diabetes , 2011, Diabetes Care.

[9]  C. Negrão,et al.  The Impact of Obstructive Sleep Apnea on Metabolic and Inflammatory Markers in Consecutive Patients with Metabolic Syndrome , 2010, PloS one.

[10]  Wei Wang,et al.  Sleep Restriction for 1 Week Reduces Insulin Sensitivity in Healthy Men , 2010, Diabetes.

[11]  J. Romijn,et al.  A single night of partial sleep deprivation induces insulin resistance in multiple metabolic pathways in healthy subjects. , 2010, The Journal of clinical endocrinology and metabolism.

[12]  Harry Whitmore,et al.  Impact of untreated obstructive sleep apnea on glucose control in type 2 diabetes. , 2010, American journal of respiratory and critical care medicine.

[13]  J. Concato,et al.  Obstructive sleep apnea as a risk factor for type 2 diabetes. , 2009, The American journal of medicine.

[14]  A. Astrup,et al.  Sleep duration as a risk factor for the development of type 2 diabetes or impaired glucose tolerance: analyses of the Quebec Family Study. , 2009, Sleep medicine.

[15]  P. Penev,et al.  Exposure to recurrent sleep restriction in the setting of high caloric intake and physical inactivity results in increased insulin resistance and reduced glucose tolerance. , 2009, The Journal of clinical endocrinology and metabolism.

[16]  S. Haffner,et al.  Sleep duration as a risk factor for incident type 2 diabetes in a multiethnic cohort. , 2009, Annals of epidemiology.

[17]  David Kelley,et al.  Obstructive Sleep Apnea Among Obese Patients With Type 2 Diabetes , 2009, Diabetes Care.

[18]  A. Bosy-Westphal,et al.  Influence of Partial Sleep Deprivation on Energy Balance and Insulin Sensitivity in Healthy Women , 2008, Obesity Facts.

[19]  E. Bixler,et al.  Selective effects of CPAP on sleep apnoea‐associated manifestations , 2008, European journal of clinical investigation.

[20]  Rachel Leproult,et al.  Slow-wave sleep and the risk of type 2 diabetes in humans , 2008, Proceedings of the National Academy of Sciences.

[21]  T. Young,et al.  Correlates of serum C-reactive protein (CRP)--no association with sleep duration or sleep disordered breathing. , 2007, Sleep.

[22]  S. Pallesen,et al.  The association between sleep duration, body mass index and metabolic measures in the Hordaland Health Study , 2007, Journal of sleep research.

[23]  M. Kerkhofs,et al.  Sleep restriction increases blood neutrophils, total cholesterol and low density lipoprotein cholesterol in postmenopausal women: A preliminary study. , 2007, Maturitas.

[24]  George A. Bray,et al.  Baseline characteristics of the randomised cohort from the Look AHEAD (Action for Health in Diabetes) study , 2006, Diabetes & vascular disease research.

[25]  E. van Cauter,et al.  Role of sleep duration and quality in the risk and severity of type 2 diabetes mellitus. , 2006, Archives of internal medicine.

[26]  T. Wadden,et al.  The Look AHEAD Study: A Description of the Lifestyle Intervention and the Evidence Supporting It , 2006, Obesity.

[27]  C. Björkelund,et al.  Sleep disturbances in midlife unrelated to 32-year diabetes incidence: the prospective population study of women in Gothenburg. , 2005, Diabetes care.

[28]  Susan Redline,et al.  Association of sleep time with diabetes mellitus and impaired glucose tolerance. , 2005, Archives of internal medicine.

[29]  M. Littner,et al.  Practice parameters for the indications for polysomnography and related procedures: an update for 2005. , 2005, Sleep.

[30]  Rachel Leproult,et al.  Leptin levels are dependent on sleep duration: relationships with sympathovagal balance, carbohydrate regulation, cortisol, and thyrotropin. , 2004, The Journal of clinical endocrinology and metabolism.

[31]  Karen C Johnson,et al.  Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. , 2003, Controlled clinical trials.

[32]  S. Redline,et al.  Short-term variablility of respiration and sleep during unattended nonlaboratory polysomnogaphy - The sleep heart health study , 2002 .

[33]  Bonnie K. Lind,et al.  Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study. , 2001, American journal of epidemiology.

[34]  P. Enright,et al.  Rates of sensor loss in unattended home polysomnography: the influence of age, gender, obesity, and sleep-disordered breathing. , 2000, Sleep.

[35]  Daniel J Buysse,et al.  Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. , 1999, Sleep.

[36]  Bonnie K. Lind,et al.  Methods for obtaining and analyzing unattended polysomnography data for a multicenter study. Sleep Heart Health Research Group. , 1998, Sleep.

[37]  J. R. Landis,et al.  An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. , 1977, Biometrics.

[38]  D. Lauderdale,et al.  Cross-Sectional Associations Between Measures of Sleep andMarkers of GlucoseMetabolism Among Subjects With andWithout Diabetes The Coronary Artery Risk Development in Young Adults (CARDIA) Sleep Study , 2011 .

[39]  A. Banga,et al.  Obesity, and not obstructive sleep apnea, is responsible for metabolic abnormalities in a cohort with sleep-disordered breathing. , 2007, Sleep medicine.

[40]  C W Whitney,et al.  Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. , 2001, American journal of respiratory and critical care medicine.

[41]  Djordje Popovic,et al.  International Archives of Medicine the Impact of Obstructive Sleep Apnea Variability Measured In-lab versus In-home on Sample Size Calculations , 2022 .